Previously, we have shown that activation of Lats2 in Akt/NRas murine liver tumors resulted in delayed hepatocarcinogenesis and the elimination of intrahepatic cholangiocarcinoma (ICC)-like lesions in the liver.9 Here, LATS2 is linked to intrahepatic cholangiocarcinoma.